Regeneron Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Great. Thanks for joining us, everybody. This is Terence Flynn. I cover the biopharma sector at Goldman Sachs. We're very pleased to have Regeneron Pharmaceuticals joining us today at our conference. We have Dr. Izzy Lowy, who is Senior Vice President, Translational Science and Oncology; and Justin Holko, who is Vice President, Investor Relations.
I think, first, Justin had some -- a statement to make, and then we're going to launch into Q&A.
Thanks, Terence, and good afternoon, everybody. We're pleased to be joining you today in this conference. As always, we will be making some forward-looking statements as it pertains to our pipeline and our business. Please refer to our SEC filings as a reference to some of the risks and uncertainties associated with the business. Any of the statements that we make may not come true, but obviously, we'll do our best to deliver on those statements.
Happy to turn it back to you
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
